These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 39004232)
1. Impact of the redox-active MnTnHex-2-PyP Soares RB; Pinto J; Amaro F; Manguinhas R; Gil N; Rosell R; Batinic-Haberle I; Fernandes AS; Oliveira NG; Guedes de Pinho P Biochem Pharmacol; 2024 Sep; 227():116424. PubMed ID: 39004232 [TBL] [Abstract][Full Text] [Related]
2. MnTnHex-2-PyP Soares RB; Manguinhas R; Costa JG; Saraiva N; Gil N; Rosell R; Camões SP; Batinic-Haberle I; Spasojevic I; Castro M; Miranda JP; Amaro F; Pinto J; Fernandes AS; Guedes de Pinho P; Oliveira NG Antioxidants (Basel); 2022 Nov; 11(11):. PubMed ID: 36358570 [TBL] [Abstract][Full Text] [Related]
3. Vermathen M; von Tengg-Kobligk H; Hungerbühler MN; Vermathen P; Ruprecht N Molecules; 2021 Nov; 26(22):. PubMed ID: 34833859 [TBL] [Abstract][Full Text] [Related]
4. CD44 variant-dependent regulation of redox balance in EGFR mutation-positive non-small cell lung cancer: A target for treatment. Kawano Y; Iwama E; Tsuchihashi K; Shibahara D; Harada T; Tanaka K; Nagano O; Saya H; Nakanishi Y; Okamoto I Lung Cancer; 2017 Nov; 113():72-78. PubMed ID: 29110853 [TBL] [Abstract][Full Text] [Related]
5. Isovitexin potentiated the antitumor activity of cisplatin by inhibiting the glucose metabolism of lung cancer cells and reduced cisplatin-induced immunotoxicity in mice. Chen RL; Wang Z; Huang P; Sun CH; Yu WY; Zhang HH; Yu CH; He JQ Int Immunopharmacol; 2021 May; 94():107357. PubMed ID: 33715980 [TBL] [Abstract][Full Text] [Related]
6. Cellular redox modulator, ortho Mn(III) meso-tetrakis(N-n-hexylpyridinium-2-yl)porphyrin, MnTnHex-2-PyP(5+) in the treatment of brain tumors. Keir ST; Dewhirst MW; Kirkpatrick JP; Bigner DD; Batinic-Haberle I Anticancer Agents Med Chem; 2011 Feb; 11(2):202-12. PubMed ID: 21291403 [TBL] [Abstract][Full Text] [Related]
8. Promotion of p53 expression and reactive oxidative stress production is involved in zerumbone-induced cisplatin sensitization of non-small cell lung cancer cells. Hu Z; Zeng Q; Zhang B; Liu H; Wang W Biochimie; 2014 Dec; 107 Pt B():257-62. PubMed ID: 25220870 [TBL] [Abstract][Full Text] [Related]
9. Bu-Zhong-Yi-Qi Decoction, the Water Extract of Chinese Traditional Herbal Medicine, Enhances Cisplatin Cytotoxicity in A549/DDP Cells through Induction of Apoptosis and Autophagy. Yu N; Xiong Y; Wang C Biomed Res Int; 2017; 2017():3692797. PubMed ID: 28154825 [TBL] [Abstract][Full Text] [Related]
10. Antitumor efficacy of the cytotoxic RNase, ranpirnase, on A549 human lung cancer xenografts of nude mice. Lee I; Kalota A; Gewirtz AM; Shogen K Anticancer Res; 2007; 27(1A):299-307. PubMed ID: 17352247 [TBL] [Abstract][Full Text] [Related]
11. Mechanism of the Antitumor and Radiosensitizing Effects of a Manganese Porphyrin, MnHex-2-PyP. Shin SW; Choi C; Lee GH; Son A; Kim SH; Park HC; Batinic-Haberle I; Park W Antioxid Redox Signal; 2017 Nov; 27(14):1067-1082. PubMed ID: 28358581 [TBL] [Abstract][Full Text] [Related]
12. Small-molecule BH3 mimetic and pan-Bcl-2 inhibitor AT-101 enhances the antitumor efficacy of cisplatin through inhibition of APE1 repair and redox activity in non-small-cell lung cancer. Ren T; Shan J; Li M; Qing Y; Qian C; Wang G; Li Q; Lu G; Li C; Peng Y; Luo H; Zhang S; Yang Y; Cheng Y; Wang D; Zhou SF Drug Des Devel Ther; 2015; 9():2887-910. PubMed ID: 26089640 [TBL] [Abstract][Full Text] [Related]
13. Circular RNA hsa_circ_0096157 contributes to cisplatin resistance by proliferation, cell cycle progression, and suppressing apoptosis of non-small-cell lung carcinoma cells. Lu H; Xie X; Wang K; Chen Q; Cai S; Liu D; Luo J; Kong J Mol Cell Biochem; 2020 Dec; 475(1-2):63-77. PubMed ID: 32767026 [TBL] [Abstract][Full Text] [Related]
14. GOLPH3 inhibition overcomes cisplatin resistance by restoring the glutathione/reactive oxygen species balance in the A549 non‑small cell lung cancer cell line. Wei Q; Lin J; Lin Z; Yu N; Wu Y; Tan X; Xue D Oncol Rep; 2024 Dec; 52(6):. PubMed ID: 39422070 [TBL] [Abstract][Full Text] [Related]
15. Allicin Overcomes Hypoxia Mediated Cisplatin Resistance in Lung Cancer Cells through ROS Mediated Cell Death Pathway and by Suppressing Hypoxia Inducible Factors. Pandey N; Tyagi G; Kaur P; Pradhan S; Rajam MV; Srivastava T Cell Physiol Biochem; 2020 Aug; 54(4):748-766. PubMed ID: 32809300 [TBL] [Abstract][Full Text] [Related]
16. Thyroid hormone enhances efficacy of cisplatin in lung cancer patients via down-regulating GLUT1 expression and reversing the Warburg effect. Fan C; Ren Y; Zhang W; Wen J; Zhang W; Lin S; Bai Y; Zheng T; Abay B; Li M; Fan L Mitochondrion; 2024 Sep; 78():101919. PubMed ID: 38876298 [TBL] [Abstract][Full Text] [Related]
17. Cisplatin-resistant NSCLC cells induced by hypoxia transmit resistance to sensitive cells through exosomal PKM2. Wang D; Zhao C; Xu F; Zhang A; Jin M; Zhang K; Liu L; Hua Q; Zhao J; Liu J; Yang H; Huang G Theranostics; 2021; 11(6):2860-2875. PubMed ID: 33456577 [TBL] [Abstract][Full Text] [Related]
18. Effect of vitamin D on malignant behavior of non-small cell lung cancer cells. Songyang Y; Song T; Shi Z; Li W; Yang S; Li D Gene; 2021 Feb; 768():145309. PubMed ID: 33197518 [TBL] [Abstract][Full Text] [Related]
19. Robust rat pulmonary radioprotection by a lipophilic Mn N-alkylpyridylporphyrin, MnTnHex-2-PyP(5+). Gauter-Fleckenstein B; Reboucas JS; Fleckenstein K; Tovmasyan A; Owzar K; Jiang C; Batinic-Haberle I; Vujaskovic Z Redox Biol; 2014; 2():400-10. PubMed ID: 24624330 [TBL] [Abstract][Full Text] [Related]
20. Disruption of NADPH homeostasis by total flavonoids from Adinandra nitida Merr. ex Li leaves triggers ROS-dependent p53 activation leading to apoptosis in non-small cell lung cancer cells. Lan T; He S; Luo X; Pi Z; Lai W; Jiang C; Gan J; Wei S; Wu Z; Yun C; Leng J; Li C J Ethnopharmacol; 2024 Oct; 332():118340. PubMed ID: 38762212 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]